% alzhub.org library filter
% Source: https://alzhub.org/research?author=Janelidze+S&year=2020
% 9 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{karikari2020-32333900,
  author  = {Karikari, T. K. and Pascoal, T. A. and Ashton, N. J. and Janelidze, S. and Benedet, A. L. and Rodriguez, J. L. and Chamoun, M. and Savard, M. and others},
  title   = {{Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts}},
  journal = {The Lancet. Neurology},
  year    = {2020},
  doi     = {10.1016/s1474-4422(20)30071-5},
  pmid    = {32333900},
  url     = {https://doi.org/10.1016/s1474-4422(20)30071-5}
}

@article{palmqvist2020-32722745,
  author  = {Palmqvist, S. and Janelidze, S. and Quiroz, Y. T. and Zetterberg, H. and Lopera, F. and Stomrud, E. and Su, Y. and Chen, Y. and others},
  title   = {{Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders}},
  journal = {JAMA},
  year    = {2020},
  doi     = {10.1001/jama.2020.12134},
  pmid    = {32722745},
  url     = {https://doi.org/10.1001/jama.2020.12134}
}

@article{janelidze2020-32123385,
  author  = {Janelidze, S. and Mattsson, N. and Palmqvist, S. and Smith, R. and Beach, T. G. and Serrano, G. E. and Chai, X. and Proctor, N. K. and others},
  title   = {{Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia}},
  journal = {Nature medicine},
  year    = {2020},
  doi     = {10.1038/s41591-020-0755-1},
  pmid    = {32123385},
  url     = {https://doi.org/10.1038/s41591-020-0755-1}
}

@article{janelidze2020-32246036,
  author  = {Janelidze, S. and Stomrud, E. and Smith, R. and Palmqvist, S. and Mattsson, N. and Airey, D. C. and Proctor, N. K. and Chai, X. and others},
  title   = {{Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease}},
  journal = {Nature communications},
  year    = {2020},
  doi     = {10.1038/s41467-020-15436-0},
  pmid    = {32246036},
  url     = {https://doi.org/10.1038/s41467-020-15436-0}
}

@article{mattssoncarlgren2020-33068398,
  author  = {Mattsson-Carlgren, N. and Janelidze, S. and Palmqvist, S. and Cullen, N. and Svenningsson, A. L. and Strandberg, O. and Mengel, D. and Walsh, D. M. and others},
  title   = {{Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease}},
  journal = {Brain : a journal of neurology},
  year    = {2020},
  doi     = {10.1093/brain/awaa286},
  pmid    = {33068398},
  url     = {https://doi.org/10.1093/brain/awaa286}
}

@article{mattssoncarlgren2020-32398359,
  author  = {Mattsson-Carlgren, N. and Leuzy, A. and Janelidze, S. and Palmqvist, S. and Stomrud, E. and Strandberg, O. and Smith, R. and Hansson, O.},
  title   = {{The implications of different approaches to define AT(N) in Alzheimer disease}},
  journal = {Neurology},
  year    = {2020},
  doi     = {10.1212/wnl.0000000000009485},
  pmid    = {32398359},
  url     = {https://doi.org/10.1212/wnl.0000000000009485}
}

@article{cullen2021-37117993,
  author  = {Cullen, N. C. and Leuzy, A. and Palmqvist, S. and Janelidze, S. and Stomrud, E. and Pesini, P. and Sarasa, L. and Allué, J. A. and others},
  title   = {{Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations}},
  journal = {Nature aging},
  year    = {2021},
  doi     = {10.1038/s43587-020-00003-5},
  pmid    = {37117993},
  url     = {https://doi.org/10.1038/s43587-020-00003-5}
}

@article{ayton2021-32882319,
  author  = {Ayton, S. and Janelidze, S. and Roberts, B. and Palmqvist, S. and Kalinowski, P. and Diouf, I. and Belaidi, A. A. and Stomrud, E. and others},
  title   = {{Acute phase markers in CSF reveal inflammatory changes in Alzheimer's disease that intersect with pathology, APOE ε4, sex and age}},
  journal = {Progress in neurobiology},
  year    = {2021},
  doi     = {10.1016/j.pneurobio.2020.101904},
  pmid    = {32882319},
  url     = {https://doi.org/10.1016/j.pneurobio.2020.101904}
}

@article{mattssoncarlgren2020-32426454,
  author  = {Mattsson-Carlgren, N. and Andersson, E. and Janelidze, S. and Ossenkoppele, R. and Insel, P. and Strandberg, O. and Zetterberg, H. and Rosen, H. J. and others},
  title   = {{Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease}},
  journal = {Science advances},
  year    = {2020},
  doi     = {10.1126/sciadv.aaz2387},
  pmid    = {32426454},
  url     = {https://doi.org/10.1126/sciadv.aaz2387}
}